Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s iShares Biotechnology ETF IBB Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-940	Closed	-$119K	–	91
2023 Q2	$119K	Hold	940	–	–	0.01%	91
2023 Q1	$120K	Hold	940	–	–	0.01%	91
2022 Q4	$124K	Buy	+940	New	+$121K	0.01%	95
2022 Q2	–	Sell	-940	Closed	-$122K	–	97
2022 Q1	$122K	Buy	+940	New	+$122K	0.01%	90
2021 Q2	–	Sell	-674	Closed	-$101K	–	92
2021 Q1	$101K	Buy	+674	New	+$107K	0.01%	70
2017 Q1	–	Sell	-32,229	Closed	-$2.87M	–	34
2016 Q4	$2.87M	Hold	32,229	–	–	1.22%	23
2016 Q3	$3.11M	Buy	+32,229	New	+$3.07M	1.21%	26

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's IBB Position: Q3 2023 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of iShares Biotechnology ETF (IBB) in Q3 2023, closing a stake of 940 shares — an estimated $119K sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in IBB in Q3 2016 and held it in 7 quarters. The position peaked at $3.11M in Q3 2016. 833 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining iShares Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 940 iShares Biotechnology ETF shares in Q3 2023, an estimated $119K.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 7 quarters.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's iShares Biotechnology ETF position peaked at $3.11M in Q3 2016.
833 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q3 2023, filed 6 Nov 2023.